.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Colorcon
Chubb
Boehringer Ingelheim
Farmers Insurance
Queensland Health
McKesson
Dow
Cantor Fitzgerald
QuintilesIMS

Generated: July 28, 2017

DrugPatentWatch Database Preview

TRIESENCE Drug Profile

« Back to Dashboard

Which patents cover Triesence, and what generic Triesence alternatives are available?

Triesence is a drug marketed by Novartis Pharms Corp and is included in one NDA. There are three patents protecting this drug.

This drug has twenty patent family members in nineteen countries.

The generic ingredient in TRIESENCE is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Eighty-three suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.

Summary for Tradename: TRIESENCE

Patents:3
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Clinical Trials: see list4
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TRIESENCE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis Pharms Corp
TRIESENCE
triamcinolone acetonide
INJECTABLE;INTRAVITREAL022048-001Nov 29, 2007RXYesYes► Subscribe► SubscribeY ► Subscribe
Novartis Pharms Corp
TRIESENCE
triamcinolone acetonide
INJECTABLE;INTRAVITREAL022048-001Nov 29, 2007RXYesYes► Subscribe► SubscribeY ► Subscribe
Novartis Pharms Corp
TRIESENCE
triamcinolone acetonide
INJECTABLE;INTRAVITREAL022048-001Nov 29, 2007RXYesYes► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: TRIESENCE

Country Document Number Estimated Expiration
Japan2011513492► Subscribe
Japan5581227► Subscribe
TaiwanI468165► Subscribe
BrazilPI0909630► Subscribe
Russian Federation2010141542► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Accenture
Johnson and Johnson
Colorcon
Deloitte
Fuji
Healthtrust
Chubb
McKinsey
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot